drugset / Trial / NCT02074267

Clinical Study for Assessment of the Efficacy of Gabapentin (Carbatin and Neurontin) in Patients With Neuropathy Pain

NCT02074267

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the efficacy of Gabapentin (Carbatin \& Neurontin) in patients with neuropathy pain.

Timeline

Start
2009-03
Primary completion
2011-06
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 300 mg Oral
Subject Gabapentin Small molecule 800 mg Oral

Indications